Liquid biopsy in breast cancer

被引：0
|
作者：
Klocker, Eva Valentina [1 ]
Suppan, Christoph [1 ]
机构：
[1] Med Univ Graz, Dept Oncol, Auenbruggerpl 15, A-8036 Graz, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2024年 / 17卷 / 3期
关键词：
ctDNA; Breast cancer; Precision medicine; Targeted therapy; MRD; Treatment response; CIRCULATING TUMOR DNA; GUIDELINE; THERAPY; OLAPARIB; CTDNA;
D O I：
10.1007/s12254-024-00975-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Currently, the main clinical application of liquid biopsy (LB) in breast cancer (BC) is the circulating tumor DNA (ctDNA)-based detection of treatment targets in metastatic or advanced disease. In this short review we focus on clinically relevant applications in BC and give a brief overview of potential future uses.
引用
收藏
页码：194 / 197
页数：4
相关论文
共 50 条
  • [41] The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring
    Openshaw, Mark Robert
    Page, Karen
    Fernandez-Garcia, Daniel
    Guttery, David
    Shaw, Jacqueline Amanda
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (07) : 751 - 755
  • [42] Liquid biopsy in cancer
    Salinas Sanchez, A. S.
    Martinez Sanchis, C.
    Gimenez Bachs, J. M.
    Garcia Olmo, D. C.
    ACTAS UROLOGICAS ESPANOLAS, 2016, 40 (01): : 1 - 2
  • [43] Cancer Liquid Biopsy
    Pan, Ying
    Ji, John S.
    Jin, Jason
    Kuo, Winston Patrick
    Kang, Hongjun
    IEEE PULSE, 2017, 8 (01) : 23 - 27
  • [44] Liquid biopsy in cancer
    Tanja, Jesenko
    Cvetka, Grasic Kuhar
    Maja, Cemazar
    ONKOLOGIJA, 2018, 22 (02) : 26 - 31
  • [45] Cell-free circulating tumour DNA as a liquid biopsy in breast cancer
    De Mattos-Arruda, Leticia
    Caldas, Carlos
    MOLECULAR ONCOLOGY, 2016, 10 (03) : 464 - 474
  • [46] Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
    Miller, Philip C.
    El-Ashry, Dorraya
    Lippman, Marc E.
    CANCER DRUG RESISTANCE, 2019, 2 (04) : 1215 - 1223
  • [47] Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer
    Keup, Corinna
    Suryaprakash, Vinay
    Hauch, Siegfried
    Storbeck, Markus
    Hahn, Peter
    Sprenger-Haussels, Markus
    Kolberg, Hans-Christian
    Tewes, Mitra
    Hoffmann, Oliver
    Kimmig, Rainer
    Kasimir-Bauer, Sabine
    GENOME MEDICINE, 2021, 13 (01)
  • [48] The use of liquid biopsy in early breast cancer: clinical evidence and future perspectives
    D'Amico, Paolo
    Corvaja, Carla
    Gerratana, Lorenzo
    Reduzzi, Carolina
    Curigliano, Giuseppe
    Cristofanilli, Massimo
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [49] Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer
    Colombo, Jucimara
    Moschetta-Pinheiro, Marina Gobbe
    Novais, Adriana Alonso
    Stoppe, Bruna Ribeiro
    Bonini, Enrico Dumbra
    Goncalves, Francine Moraes
    Fukumasu, Heidge
    Coutinho, Luiz Lehmann
    de Almeida Chuffa, Luiz Gustavo
    Pires de Campos Zuccari, Debora Aparecida
    CANCERS, 2021, 13 (20)
  • [50] Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
    Fackler, Mary Jo
    Tulac, Suzana
    Venkatesan, Neesha
    Aslam, Adam J.
    de Guzman, Timothy N.
    Mercado-Rodriguez, Claudia
    Cope, Leslie M.
    Downs, Bradley M.
    Vali, Abdul Hussain
    Ding, Wanjun
    Lehman, Jennifer
    Denbow, Rita
    Reynolds, Jeffrey
    Buckley, Morgan E.
    Visvanathan, Kala
    Umbricht, Christopher B.
    Wolff, Antonio C.
    Stearns, Vered
    Bates, Michael
    Lai, Edwin W.
    Sukumar, Saraswati
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (06): : 391 - 401
12345